Patents by Inventor John Bogdan

John Bogdan has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Patent number: 11990309
    Abstract: Various systems and methods are provided for a biased cathode assembly of an X-ray tube with improved thermal management and a method of manufacturing same. In one example, a cathode assembly of an X-ray tube comprises an emitter assembly including an emitter coupled to an emitter support structure, and an electrode assembly including an electrode stack and a plurality of bias electrodes. The emitter assembly including a plurality of independent components that are coupled together. The electrode assembly including a plurality of independent components that are coupled together, and the emitter assembly being coupled to the electrode assembly.
    Type: Grant
    Filed: October 31, 2022
    Date of Patent: May 21, 2024
    Assignee: GE Precision Healthcare LLC
    Inventors: Andrew Thomas Cross, Uwe Wiedmann, Marshall Gordon Jones, Carey Rogers, John Scott Price, Joseph Darryl Michael, Sergio Lemaitre, Fulton Jose Lopez, Vasile Bogdan Neculaes, Steve Buresh, David Wagner
  • Patent number: 11926815
    Abstract: A system, methods, and apparatus are described to collect and prepare single cells, nuclei, subcellular components, and biomolecules from specimens including tissues and in some embodiments use the single cells to form organoids or microtissues. The system can perform enzymatic and/or physical disruption of the tissue to dissociate it into single-cells and then use a hanging droplet method to form organoids or microtissues.
    Type: Grant
    Filed: March 9, 2023
    Date of Patent: March 12, 2024
    Assignee: S2 GENOMICS, INC.
    Inventors: Stevan Bogdan Jovanovich, Kaiwan Chear, Bruce Leisz, David Eberhart, John Bashkin
  • Patent number: 11920016
    Abstract: This invention relates to thermoset, thermal insulating panel, pour-in-place and pour-in-place foams having desirable and unexpectedly low thermal conductivity, and to compositions, method and systems which use and/or are used to make such foams comprising: (a) providing thermosetting foam forming component and a blowing agent for forming predominantly closed cells in the foam, wherein the blowing agent comprises: (i) cis-1,1,1,4,4,4-hexafluoro-2-butene (HFO-1336mzzm(Z)) and cyclopentane, with the HFO-1336mzzm(Z) and cyclopentane in the blowing agent together comprising at least about 50% by weight of the total of all components in the blowing agent and (ii) the weight ratio of HFO-1336mzzm(Z) to cyclopentane in the blowing agent is from about 45:55 to less than 68:32 and (b) forming foam from said provided foamable composition.
    Type: Grant
    Filed: November 10, 2021
    Date of Patent: March 5, 2024
    Assignee: HONEYWELL INTERNATIONAL INC.
    Inventors: Bin Yu, Mary C. Bogdan, David John Williams, Yiu Keung Ling
  • Publication number: 20210255530
    Abstract: A wall controller is provided. The wall controller includes a projection screen having an input device and a projector arranged to project a digital image onto the projection screen from the projector, wherein the projector has an optical axis that is non-orthogonal to the projection screen. The wall controller includes a housing having the projection screen mounted thereto at a first end of the housing, the housing having the projector at a second end of the housing. The housing is dimensioned to fit the second end of the housing through an aperture in a first wall, fit the second end into a wall space between the first wall and a second wall, and fit a majority of the first end of the housing into the aperture until the projection screen is parallel to a surface of the first wall and a front portion of the projection screen is flush with, recessed in or extends from the surface of the first wall. The aperture dimensioned to fit the first end of the housing or the front portion of the projection screen.
    Type: Application
    Filed: February 15, 2021
    Publication date: August 19, 2021
    Inventors: Antoine Dubois, John Bogdan, Paul Nagel, Craig Henricksen, Stephen Coffin, Wally Barnum
  • Patent number: 10921694
    Abstract: A wall controller is provided. The wall controller includes a projection screen arranged to project a digital image onto the projection screen from the projector, wherein the projector has an optical axis that is non-orthogonal to the projection screen. The wall controller includes a housing having the projection screen mounted thereto. A housing is dimensioned to fit a second end of the housing through an aperture in a first wall, fit the second end into a wall space between the first wall and a second wall, and fit a majority of the first end of the housing into the aperture until the projection screen is parallel to a surface of the first wall. The aperture dimensioned to fit the first end of the housing or the front portion of the projection screen.
    Type: Grant
    Filed: January 21, 2020
    Date of Patent: February 16, 2021
    Assignee: KINESTRAL TECHNOLOGIES, INC
    Inventors: Antoine Dubois, John Bogdan, Paul Nagel, Craig Henricksen, Stephen Coffin, Wally Barnum
  • Publication number: 20200159096
    Abstract: A wall controller is provided. The wall controller includes a projection screen having an input device and a projector arranged to project a digital image onto the projection screen from the projector, wherein the projector has an optical axis that is non-orthogonal to the projection screen. The wall controller includes a housing having the projection screen mounted thereto at a first end of the housing, the housing having the projector at a second end of the housing. The housing is dimensioned to fit the second end of the housing through an aperture in a first wall, fit the second end into a wall space between the first wall and a second wall, and fit a majority of the first end of the housing into the aperture until the projection screen is parallel to a surface of the first wall and a front portion of the projection screen is flush with, recessed in or extends from the surface of the first wall. The aperture dimensioned to fit the first end of the housing or the front portion of the projection screen.
    Type: Application
    Filed: January 21, 2020
    Publication date: May 21, 2020
    Inventors: Antoine Dubois, John Bogdan, Paul Nagel, Craig Henricksen, Stephen Coffin, Wally Barnum
  • Patent number: 10539860
    Abstract: A wall controller is provided. The wall controller includes a projection screen having an input device and a projector, wherein the projector has an optical axis that is non-orthogonal to the projection screen. The wall controller includes a housing having the projector at an end of the housing. The housing is dimensioned to fit the end of the housing through an aperture in a first wall, fit the end into a wall space between the first wall and a second wall, and fit a majority of another end of the housing into the aperture until the projection screen is parallel to a surface of the first wall and a front portion of the projection screen is flush with, recessed in or extends from the surface of the first wall.
    Type: Grant
    Filed: August 30, 2017
    Date of Patent: January 21, 2020
    Assignee: Kinestral Technologies, Inc.
    Inventors: Antoine Dubois, John Bogdan, Paul Nagel, Craig Henricksen, Stephen Coffin, Wally Barnum
  • Publication number: 20180059520
    Abstract: A wall controller is provided. The wall controller includes a projection screen having an input device and a projector arranged to project a digital image onto the projection screen from the projector, wherein the projector has an optical axis that is non-orthogonal to the projection screen. The wall controller includes a housing having the projection screen mounted thereto at a first end of the housing, the housing having the projector at a second end of the housing. The housing is dimensioned to fit the second end of the housing through an aperture in a first wall, fit the second end into a wall space between the first wall and a second wall, and fit a majority of the first end of the housing into the aperture until the projection screen is parallel to a surface of the first wall and a front portion of the projection screen is flush with, recessed in or extends from the surface of the first wall. The aperture dimensioned to fit the first end of the housing or the front portion of the projection screen.
    Type: Application
    Filed: August 30, 2017
    Publication date: March 1, 2018
    Applicant: Kinestral Technologies, Inc.
    Inventors: Antoine Dubois, John Bogdan, Paul Nagel, Craig Henricksen, Stephen Coffin, Wally Barnum
  • Patent number: 7829321
    Abstract: Methods and compositions are provided for the enhanced production of bacterial toxins in large-scale cultures. Specifically, methods and compositions for reducing bacterial toxin expression inhibitors are providing including, but not limited to, addition of toxin expression inhibitor binding compounds, culture media having reduced concentrations of toxin inhibitor metabolic precursors and genetically modified toxogenic bacteria lacking enzymes required to metabolize the toxin inhibitor metabolic precursors.
    Type: Grant
    Filed: November 29, 2005
    Date of Patent: November 9, 2010
    Assignees: Baxter International Inc., Baxter Healthcare S.A.
    Inventors: Milan S. Blake, John A. Bogdan, Jr., Javier Nazario-Larrieu
  • Patent number: 7790185
    Abstract: Methods and compositions are provided for the enhanced production of bacterial toxins in large-scale cultures. Specifically, methods and compositions for reducing bacterial toxin expression inhibitors are providing including, but not limited to, addition of toxin expression inhibitor binding compounds, culture media having reduced concentrations of toxin inhibitor metabolic precursors and genetically modified toxogenic bacteria lacking enzymes required to metabolize the toxin inhibitor metabolic precursors.
    Type: Grant
    Filed: November 1, 2005
    Date of Patent: September 7, 2010
    Assignees: Baxter International Inc., Bacter Healthcare S.A.
    Inventors: Milan S. Blake, John A. Bogdan, Jr., Javier Nazario-Larrieu
  • Publication number: 20070160229
    Abstract: This invention relates to a noise filtering edge detector (NFED) for recovering data carrying edges from a noisy received signal by dense over-sampling of the received signal and by detecting edge phases and edge amplitude limits wherein recovered signal amplitudes at sampling instance defining said edge phase are determined by said edge amplitude limits while recovered amplitudes assumed at sampling instances following the last edge detected are those implementing an ideal signal shape determined by the last edge. The NFED comprises a system for adaptive noise filtering which analyzes captured unfiltered portions of the over-sampled waveform in order to compensate predictable and/or random signal distortions and interferences.
    Type: Application
    Filed: January 7, 2005
    Publication date: July 12, 2007
    Inventor: John Bogdan
  • Publication number: 20060238240
    Abstract: The DSP MSP invention provides an implementation of programmable algorithms for analyzing a very wide range of low and high frequency wave-forms. The DSP MSP comprises a synchronous sequential processor (SSP) for real time capturing and processing of in-coming wave-form and a programmable computing unit (PCU) for controlling SSP operations and supporting adaptive signal analysis algorithms. The DSP MSP further comprises a circuit for Sequential Data Recovery from Multi Sampled Phase (SDR MSP), for a receiver of an optical waveform.
    Type: Application
    Filed: June 25, 2003
    Publication date: October 26, 2006
    Inventor: John Bogdan
  • Publication number: 20060216789
    Abstract: Methods and compositions are provided for the enhanced production of bacterial toxins in large-scale cultures. Specifically, methods and compositions for reducing bacterial toxin expression inhibitors are providing including, but not limited to, addition of toxin expression inhibitor binding compounds, culture media having reduced concentrations of toxin inhibitor metabolic precursors and genetically modified toxogenic bacteria lacking enzymes required to metabolize the toxin inhibitor metabolic precursors.
    Type: Application
    Filed: November 1, 2005
    Publication date: September 28, 2006
    Applicants: Baxter International Inc., Baxter Healthcare S.A.
    Inventors: Milan Blake, John Bogdan, Javier Nazario-Larrieu
  • Publication number: 20060204955
    Abstract: Methods and compositions are provided for the enhanced production of bacterial toxins in large-scale cultures. Specifically, methods and compositions for reducing bacterial toxin expression inhibitors are providing including, but not limited to, addition of toxin expression inhibitor binding compounds, culture media having reduced concentrations of toxin inhibitor metabolic precursors and genetically modified toxogenic bacteria lacking enzymes required to metabolize the toxin inhibitor metabolic precursors.
    Type: Application
    Filed: November 29, 2005
    Publication date: September 14, 2006
    Applicants: Baxter Healthcare S.A, Baxter International Inc.
    Inventors: Milan Blake, John Bogdan, Javier Nazario-Larrieu
  • Patent number: 7045314
    Abstract: Methods and compositions are provided for the enhanced production of bacterial toxins in large-scale cultures. Specifically, methods and compositions for reducing bacterial toxin expression inhibitors are providing including, but not limited to, addition of toxin expression inhibitor binding compounds, culture media having reduced concentrations of toxin inhibitor metabolic precursors and genetically modified toxogenic bacteria lacking enzymes required to metabolize the toxin inhibitor metabolic precursors.
    Type: Grant
    Filed: April 4, 2001
    Date of Patent: May 16, 2006
    Assignees: Baxter International Inc., Baxter Healthcare S.A.
    Inventors: Milan S. Blake, John A. Bogdan, Jr., Javier Nazario-Larrieu
  • Patent number: 7018813
    Abstract: Methods and compositions are provided for the enhanced production of bacterial toxins in large-scale cultures. Specifically, methods and compositions for reducing bacterial toxin expression inhibitors are providing including, but not limited to, addition of toxin expression inhibitor binding compounds, culture media having reduced concentrations of toxin inhibitor metabolic precursors and genetically modified toxogenic bacteria lacking enzymes required to metabolize the toxin inhibitor metabolic precursors.
    Type: Grant
    Filed: October 3, 2003
    Date of Patent: March 28, 2006
    Assignees: Baxter International Inc., Baxter Healthcare S.A.
    Inventors: Milan S. Blake, John A. Bogdan, Jr., Javier Nazario-Larrieu
  • Publication number: 20050212565
    Abstract: An inexpensive, reliable and high quality digital phase frequency synthesis method and circuit providing universal transmission synchronizer for wireless, optical, or wireline transmission systems and for a wide range of data rates. In particular this invention enables the transmission synchronizer to produce a variety of network element synchronization clocks fulfilling a programmable phase transfer function versus external synchronization clocks. The transmission synchronizer designed in accordance with this invention integrates comprehensive programmable reference monitoring, phase transfer processing, reference switching and protection switching functions into a single integrated circuit; based on high resolution synthesized clock generator, high resolution digital phase detectors, and efficient on chip system architecture.
    Type: Application
    Filed: December 2, 2002
    Publication date: September 29, 2005
    Inventor: John Bogdan
  • Publication number: 20050100553
    Abstract: Methods and compositions are provided for the enhanced production of bacterial toxins in large-scale cultures. Specifically, methods and compositions for reducing bacterial toxin expression inhibitors are providing including, but not limited to, addition of toxin expression inhibitor binding compounds, culture media having reduced concentrations of toxin inhibitor metabolic precursors and genetically modified toxogenic bacteria lacking enzymes required to metabolize the toxin inhibitor metabolic precursors.
    Type: Application
    Filed: October 3, 2003
    Publication date: May 12, 2005
    Applicant: Baxter Healthcare S.A.
    Inventors: Milan Blake, John Bogdan, Javier Nazario-Larrieu
  • Patent number: D520553
    Type: Grant
    Filed: July 8, 2005
    Date of Patent: May 9, 2006
    Assignee: Harman International Industries, Incorporated
    Inventors: John Bogdan, Paul Howard, Robin M. Urry
  • Patent number: D688731
    Type: Grant
    Filed: January 7, 2011
    Date of Patent: August 27, 2013
    Assignee: Harman International Industries, Incorporated
    Inventors: John Bogdan, Jim Pennock, William Clements